All News

Beer and Cider Associated with Higher Risk of Gout in Both Sexes vs Other Alcohol Types
October 14, 2024

Higher alcohol intake was associated with a greater risk of gout for both sexes, but the correlation was stronger in men than women, according to a recent study.

After a False Positive Result, Screening Mammography May Not be a Priority for Some Women
October 14, 2024

The group of women least likely to return for a regular preventive screening mammogram after a false positive result surprised this primary investigator.

Sotagliflozin in Patients with Type 1 Diabetes and CKD to be Discussed at October FDA AdComm Meeting
October 14, 2024

Lexicon's sotagliflozin is on the October 31 docket for discussion by the FDA's Endocrinologic and Metabolic Drugs Advisory Committee; PDUFA goal date remains set for December 20.

Effectiveness of Suicide Care Implementation in Primary Care: Daily Dose
October 14, 2024

Your daily dose of the clinical news you may have missed.

Elinzanetant Update: FDA Accepts Bayer NDA, Sets July 2025 PDUFA Date
October 11, 2024

The elinzanetant NDA is based on data, including long-term efficacy, from the OASIS phase 3 clinical trial program, according to Bayer.

Researcher Explains How Women Respond to a False Positive Breast Cancer Screening Result
October 11, 2024

After a false positive outcome on screening mammography, a short interval call back for repeat imaging was a significant deterrent to future screening.

RSV Mortality Higher than for Influenza B After Hospital Discharge: Daily Dose
October 11, 2024

Your daily dose of the clinical news you may have missed.

Single vs Multiple Inhaler Triple Therapy for COPD Could Triple Adherence, Persistence: International Data
October 11, 2024

CHEST 2024: Combined data from 4 continents found consistently better adherence/persistence when COPD triple therapy was initiated with a single inhaler.

Remdesivir Plus Dexamethasone Reduces Mortality Risk among Adults Hospitalized with COVID-19
October 10, 2024

Remdesivir plus dexamethasone was associated with reduced 14- and 28-day mortality vs dexamethasone alone, according to a large study of adults hospitalized with COVID-19.

Early Identification, Treatment of COPD Reduces Exacerbations, Health Care Burden
October 10, 2024

CHEST 2024. Initial treatment for people with COPD should begin early in the disease and leads to significantly reduced risk for exacerbations and inpatient treatment.